In the SURPASS clinical trials, participants were free to take their injections at any time of day
The unexpectedly profound weight loss observed in diabetes trials drove development of a higher-dose formulation Wegovy (up to 2.4 mg weekly) which received FDA approval in 2021 and EMA approval in 2023 specifically for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
Women who are pregnant or nursing should also stay away from GLP-1 agonists because it is unclear how they will affect the growth of the fetus or the supply of breast milk
Compounded vs Brand-Name Semaglutide Cost and Regulatory Distinction Compounded semaglutide contains the same active molecule (semaglutide) as Ozempic (approved for type 2 diabetes) and Wegovy (approved for chronic weight management), prepared by FDA-registered 503B facilities under federal oversight or state-licensed compounding pharmacies regulated by state boards of pharmacy
And when people arent wrestling with portion control or cravings, they can notice that even though they arent eating as much, they still feel okay
When the effort required by rodents to obtain palatable food was assessed, exendin-4 was found to decrease operant responding on both fixed and progressive ratio schedules, further supporting a reduction in the motivational drive for palatable foods (Bernosky-Smith et al., 2016)